Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Age-Related Molecular Degeneration IndustryAge-related molecular degeneration industry size has a projected US$ 11.28 million market valuation worldwide in 2023, with a compound annual growth rate (CAGR) of 7%. By 2033, the healthcare technology industry is anticipated to reach US$ 22.19 million due to technologica...
The FDA has accepted for Priority Review the BLA for omalizumab for the reduction of allergic reactions in patients with food allergies.
MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine capsules)-assisted therapy for posttraumatic stress disorder.
– If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure – – Interim analysis results from first-of-its-kind Phase III...
MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it...